Objective: To examine the relationship between selenium nutritional status and intermediates of human immunodeficiency virus (HIV)-1 transmission. Design: Prospective cohort study. Setting: A study clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Subjects: A total of 340 HIV-1-infected pregnant women with gestational ages 12-27 weeks. Methods: Women's plasma selenium concentrations were determined at enrollment and modeled as tertiles (tertile 1: o114 mg/l (reference); tertile 2: 114-131 mg/l; tertile 3: 4131 mg/l). Cervicovaginal lavage specimens were obtained at 36 weeks of gestation to determine HIV-1 RNA and interleukin-1b (IL-1b) levels. In subgroup analyses, 123 women with genital tract infections at enrollment were excluded. Results: Plasma selenium concentrations X114 mg/l were related to increased risk of lower-genital shedding of HIV-1 RNA. Excluding women with genital tract infections strengthened the associations (relative risk (RR) tertile 2: 1.46, 95% confidence interval (CI) ¼ 1.10, 1.92; RR tertile 3: 1.39, 95% CI ¼ 1.05, 1.84). There was evidence for an association between plasma selenium concentrations X114 mg/l and increased HIV-1 RNA levels among the entire cohort and after excluding women with genital tract infections. There was no association between plasma selenium and IL-1b concentrations. Conclusions: High selenium status may lead to increased risk of genital HIV-1 shedding, but data from other studies indicate that the evidence is mixed. Results from ongoing selenium trials are awaited to clarify the impact of selenium on HIV-1-related transmission endpoints.